+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID04074720

Prospective Study Collecting Breast Cancer Tissue, Blood, and Optional Biome Samples During Standard Treatment Procedures

Led by Thomas Jefferson University · Updated on 2025-12-03

200

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are collecting breast cancer tissue and blood samples from patients undergoing standard care procedures to study tumor biomarkers and genomic profiles. The study focuses on patients with invasive breast cancer, carcinoma in situ, or those with brain metastases from breast cancer. This research aims to improve understanding of breast cancer biology by analyzing collected biospecimens over up to five years. All participants will have tissue samples collected during procedures they are already scheduled to undergo, such as tumor resection, vascular access device placement, or brain metastasis surgery. A one-time blood draw will also be performed on the day of the procedure. Participants may optionally provide a rectal swab for biome analysis. There is no randomization or assignment to different treatment groups since this is an observational study. Participants will undergo tissue and blood collection only once, with optional biome specimen collection. Afterward, follow-up consists solely of reviewing medical records to track recurrence, metastases, and survival outcomes for up to five years. The main outcome measured is tumor biomarker identification, along with laboratory-based genomic tumor profiling. This approach allows researchers to study disease progression without changing standard care.

CONDITIONS

Brief Title

Prospective Breast Cancer Biospecimen Collection

Research Team

N

Nicole Simone, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here